Pt Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 30, 2021
Share
PT Kalbe Farma Tbk. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was IDR 6,015,414.546 million compared to IDR 5,795,613.126 million a year ago. Net income was IDR 716,465.649 million compared to IDR 669,269.022 million a year ago. Basic earnings per share from continuing operations was IDR 15.29 compared to IDR 14.28 a year ago.
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
PT KALBE FARMA TBK. 
